Information Library
Results for: Oncology - Asia
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Energizing Enrollment
Case Study — October 4, 2011
The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. -
Genomics Fact Sheet
Brochure — June 17, 2011
Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area. -
Oncology Expertise - Scientific Collaborator for Global Solutions
Brochure — January 28, 2011
Whether you wish to use one of our existing assays, need assistance with developing a new assay, or plan to deploy an assay developed by your diagnostic partner, as your collaborator, Quintiles has the scientific expertise, resources, and flexibility to develop the right solution for you. -
Quintiles Speeds Early-Phase Decision Making with New Unit in Hyderabad, India
Press Release — January 24, 2011 – Quintiles officially opened its new Phase I research facility in Hyderabad, India at Apollo Health City.
-
The Secrets to Successful Study Management
Presentation — November 2, 2010
Meg Hooten's presentation "The Secrets to Successful Study Management" at AusBiotech 2010 -
HUYA, QUINTILES ANNOUNCE PARTNERSHIP TO CO-DEVELOP CANCER THERAPY
Press Release — September 28, 2010 - HUYA Bioscience International (HUYA) and Quintiles announced an agreement to co-develop a new cancer drug, HBI-8000, sourced in China by HUYA.
-
QUINTILES ANNOUNCES SUITE OF PI3K BIOMARKER ASSAYS TO ADVANCE ONCOLOGY THERAPIES TARGETING THIS CANCER PATHWAY
Press Release — June 7, 2010 - Suite is part of Quintiles Global Central Labs’ ongoing efforts to advance personalized medicine.
-
Commercial – Identify, Promote and Prove Treatment Value
Brochure — April 1, 2010
Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. -
Quintiles’ Christopher Ung Discusses the Future of Biomarkers, Digital Pathology and Personalized Medicine in PharmaAsia
Media Coverage — February 9, 2010
Christopher Ung, Vice President, Strategic Business and Operations, Oncology, recently authored an article on biomarkers, digital pathology and the future of personalized medicine for the -
Validated Biomarker Menu
Brochure — July 14, 2009
A comprehensive menu of validated cell, fluid and tissue based biomarker assays.
Page 1 of 1 (10 results)
